PL2872497T3 - Pochodne chromanylowe do leczenia choroby mitochondrialnej - Google Patents
Pochodne chromanylowe do leczenia choroby mitochondrialnejInfo
- Publication number
- PL2872497T3 PL2872497T3 PL13759838T PL13759838T PL2872497T3 PL 2872497 T3 PL2872497 T3 PL 2872497T3 PL 13759838 T PL13759838 T PL 13759838T PL 13759838 T PL13759838 T PL 13759838T PL 2872497 T3 PL2872497 T3 PL 2872497T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- mitochondrial disease
- chromanyl
- derivatives
- chromanyl derivatives
- Prior art date
Links
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 title 1
- 208000012268 mitochondrial disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261670644P | 2012-07-12 | 2012-07-12 | |
| EP12176128 | 2012-07-12 | ||
| EP13759838.9A EP2872497B2 (en) | 2012-07-12 | 2013-07-12 | Chromanyl derivatives for treating mitochondrial disease |
| PCT/NL2013/050528 WO2014011047A1 (en) | 2012-07-12 | 2013-07-12 | Chromanyl derivatives for treating mitochondrial disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL2872497T3 true PL2872497T3 (pl) | 2017-07-31 |
| PL2872497T5 PL2872497T5 (pl) | 2020-02-28 |
Family
ID=49916367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13759838T PL2872497T5 (pl) | 2012-07-12 | 2013-07-12 | Pochodne chromanylowe do leczenia choroby mitochondrialnej |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP2872497B2 (pl) |
| JP (1) | JP6292721B2 (pl) |
| KR (1) | KR102137450B1 (pl) |
| CN (1) | CN104662011B (pl) |
| AU (1) | AU2013287347B2 (pl) |
| CA (1) | CA2878567C (pl) |
| DK (1) | DK2872497T4 (pl) |
| ES (1) | ES2622190T5 (pl) |
| HU (1) | HUE033757T2 (pl) |
| LT (1) | LT2872497T (pl) |
| PL (1) | PL2872497T5 (pl) |
| PT (1) | PT2872497T (pl) |
| RS (1) | RS55813B2 (pl) |
| SI (1) | SI2872497T2 (pl) |
| SM (1) | SMT201700195T1 (pl) |
| WO (1) | WO2014011047A1 (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106536056B (zh) | 2014-06-13 | 2021-07-16 | 儿童医学中心公司 | 分离线粒体的产品和方法 |
| MX388654B (es) * | 2015-05-22 | 2025-03-20 | Sulfateq Bv | Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón. |
| WO2016190852A1 (en) * | 2015-05-26 | 2016-12-01 | Stealth Peptides International, Inc. | Therapeutic compositions including chromanyl compounds, variants and analogues thereof, and uses thereof |
| US10815211B2 (en) | 2015-10-08 | 2020-10-27 | Khondrion Ip B.V. | Compounds for treating mitochondrial disease |
| WO2017124037A1 (en) * | 2016-01-15 | 2017-07-20 | The Children's Medical Center Corporation | Therapeutic use of mitochondria and combined mitochondrial agents |
| KR101816277B1 (ko) * | 2016-10-06 | 2018-01-08 | 가천대학교 산학협력단 | 8-옥소-데옥시구아노신(8-oxo-2'-deoxyguanosine) 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 각막 손상 치료용 약학적 조성물 |
| ES2959243T3 (es) | 2017-04-05 | 2024-02-22 | Khondrion Ip B V | Nuevo tratamiento de enfermedades mitocondriales |
| SG11202003743SA (en) * | 2017-11-22 | 2020-06-29 | Khondrion Ip B V | Compounds as mpges-1 inhibitors |
| KR102782169B1 (ko) * | 2017-11-22 | 2025-03-17 | 콘드리온 아이피 비.브이. | 우울증 및 편두통 치료용 신규 화합물 |
| WO2020152336A1 (en) | 2019-01-25 | 2020-07-30 | Universitat Autonoma De Barcelona | Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases |
| CN121949079A (zh) * | 2019-10-04 | 2026-05-01 | 康德生物医疗有限公司 | 治疗线粒体异常疾病的伐替苯醌的醌、氢醌和萘醌类似物 |
| NL2024431B1 (en) * | 2019-12-11 | 2021-09-07 | Sulfateq Bv | Compounds for treatment of alzheimer’s disease |
| CN115996916B (zh) | 2020-04-03 | 2025-09-23 | 康德生物医疗有限公司 | 用于预防和/或治疗包括弗里德赖希共济失调的线粒体疾病的组合物和方法 |
| NL2025730B1 (en) | 2020-06-02 | 2022-01-20 | Sulfateq Bv | Compounds for treatment of sepsis |
| NL2026511B1 (en) | 2020-09-21 | 2022-05-24 | Sulfateq Bv | Compounds for treatment of heart failure |
| NL2031091B1 (en) | 2022-02-28 | 2023-09-07 | Sulfateq Bv | Chromanol compounds for treatment or prophylaxis of ageing and ageing-associated disorders |
| WO2025242849A1 (en) | 2024-05-24 | 2025-11-27 | Khondrion Ip B.V. | Chromanyl derivatives for use in the treatment of bone disorders |
| EP4729606A1 (en) | 2024-10-17 | 2026-04-22 | Sulfateq B.V. | Methods for the cryopreservation of cells |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1338012C (en) * | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
| JPH02250831A (ja) * | 1989-03-23 | 1990-10-08 | Kuraray Co Ltd | 3,4―ジヒドロ―2h―ベンゾピラン誘導体及びそれを有効成分とする抗消化性潰瘍剤 |
| FR2676056B1 (fr) | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JP3093170B2 (ja) * | 1996-09-19 | 2000-10-03 | 株式会社ジャパンエナジー | ヒドロキノン誘導体及びその医薬用途 |
| FR2764889B1 (fr) * | 1997-06-20 | 2000-09-01 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| FR2761066B1 (fr) * | 1997-03-24 | 2000-11-24 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| JPH11106371A (ja) * | 1997-07-04 | 1999-04-20 | Nisshin Flour Milling Co Ltd | アシルヒドラゾン誘導体 |
| AR019190A1 (es) * | 1998-07-08 | 2001-12-26 | Sod Conseils Rech Applic | Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos |
| WO2000006550A1 (en) * | 1998-07-31 | 2000-02-10 | Nippon Soda Co., Ltd. | Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| FR2783519B1 (fr) * | 1998-09-23 | 2003-01-24 | Sod Conseils Rech Applic | Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| AU2001262200A1 (en) * | 2000-04-25 | 2001-11-07 | Schering Aktiengesellschaft | Benzoxazine derivatives and benzothiazine derivatives having nos-inhibitory and antioxidant properties |
| GR1003725B (el) | 2000-07-12 | 2001-11-27 | Νεες ενωσεις με συνδυασμενη αντιοξειδωτικη και αντιαρρυθμικη δραση | |
| JP2002047272A (ja) * | 2000-07-26 | 2002-02-12 | Dai Ichi Seiyaku Co Ltd | ポリアミンアミド誘導体 |
| NZ513547A (en) | 2001-08-13 | 2002-09-27 | Antipodean Biotechnology Ltd | Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone) |
| JP2003212872A (ja) * | 2002-01-23 | 2003-07-30 | Japan Energy Corp | 新規クロマン誘導体及びその医薬用途 |
| GB0204232D0 (en) | 2002-02-22 | 2002-04-10 | Isis Innovation | Assay |
| WO2005012293A1 (ja) * | 2003-08-01 | 2005-02-10 | Nippon Soda Co., Ltd. | フェニルアゾール化合物、製造法および抗酸化薬 |
| WO2005033093A1 (en) † | 2003-09-19 | 2005-04-14 | Galileo Pharmaceuticals, Inc. | 7,8-bicycloalkyl-chroman derivatives |
| JP2008019188A (ja) * | 2006-07-11 | 2008-01-31 | Hamari Chemicals Ltd | 新規カルノシン誘導体及び組成物 |
| EA038941B1 (ru) * | 2007-11-06 | 2021-11-12 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ |
| SG187744A1 (en) | 2010-08-06 | 2013-03-28 | Edison Pharmaceuticals Inc | Treatment of mitochondrial diseases with naphthoquinones |
| WO2012019032A1 (en) | 2010-08-06 | 2012-02-09 | Ampere Life Sciences, Inc. | Treatment of mitochondrial diseases with vitamin k |
| NL2010010C2 (en) | 2012-12-19 | 2014-06-23 | Sulfateq B V | Compounds for protection of cells. |
-
2013
- 2013-07-12 KR KR1020157000618A patent/KR102137450B1/ko active Active
- 2013-07-12 EP EP13759838.9A patent/EP2872497B2/en active Active
- 2013-07-12 DK DK13759838T patent/DK2872497T4/da active
- 2013-07-12 RS RS20170348A patent/RS55813B2/sr unknown
- 2013-07-12 CA CA2878567A patent/CA2878567C/en active Active
- 2013-07-12 PT PT137598389T patent/PT2872497T/pt unknown
- 2013-07-12 SI SI201330603T patent/SI2872497T2/sl unknown
- 2013-07-12 PL PL13759838T patent/PL2872497T5/pl unknown
- 2013-07-12 AU AU2013287347A patent/AU2013287347B2/en active Active
- 2013-07-12 WO PCT/NL2013/050528 patent/WO2014011047A1/en not_active Ceased
- 2013-07-12 ES ES13759838T patent/ES2622190T5/es active Active
- 2013-07-12 HU HUE13759838A patent/HUE033757T2/en unknown
- 2013-07-12 LT LTEP13759838.9T patent/LT2872497T/lt unknown
- 2013-07-12 CN CN201380037183.8A patent/CN104662011B/zh active Active
- 2013-07-12 SM SM20170195T patent/SMT201700195T1/it unknown
- 2013-07-12 JP JP2015521570A patent/JP6292721B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104662011A (zh) | 2015-05-27 |
| EP2872497A1 (en) | 2015-05-20 |
| SMT201700195T1 (it) | 2017-05-08 |
| ES2622190T5 (es) | 2020-04-23 |
| AU2013287347B2 (en) | 2017-11-30 |
| JP6292721B2 (ja) | 2018-03-14 |
| PT2872497T (pt) | 2017-04-24 |
| CN104662011B (zh) | 2017-09-29 |
| WO2014011047A1 (en) | 2014-01-16 |
| KR102137450B1 (ko) | 2020-07-27 |
| ES2622190T3 (es) | 2017-07-05 |
| EP2872497B1 (en) | 2017-03-08 |
| HUE033757T2 (en) | 2017-12-28 |
| JP2015522067A (ja) | 2015-08-03 |
| DK2872497T3 (en) | 2017-04-24 |
| PL2872497T5 (pl) | 2020-02-28 |
| DK2872497T4 (da) | 2019-11-25 |
| EP2872497B2 (en) | 2019-10-09 |
| RS55813B1 (sr) | 2017-08-31 |
| AU2013287347A1 (en) | 2015-01-22 |
| SI2872497T1 (sl) | 2017-08-31 |
| KR20150036035A (ko) | 2015-04-07 |
| CA2878567C (en) | 2021-02-23 |
| CA2878567A1 (en) | 2014-01-16 |
| SI2872497T2 (sl) | 2019-12-31 |
| RS55813B2 (sr) | 2019-12-31 |
| LT2872497T (lt) | 2017-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022027I2 (el) | Παραγωγα βενζιμιδαζολο-προλινης | |
| IL289300A (en) | Combination therapy for treating cancer | |
| PL2872497T3 (pl) | Pochodne chromanylowe do leczenia choroby mitochondrialnej | |
| CY2019033I1 (el) | Μακροκυκλικα παραγωγα για την αγωγη υπερπλαστικων παθησεων | |
| IL262956B (en) | Methods for increasing efficacy of folr1 cancer therapy | |
| LT3470063T (lt) | Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui | |
| HRP20182069T1 (hr) | Farmaceutski pripravci za liječenje alzheimerove bolesti | |
| IL235734B (en) | Process for the preparation of treprostinil and derivatives thereof | |
| DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
| AR092198A1 (es) | Derivados de pirazolopirimidinas | |
| EP2872120A4 (en) | TARGETED THERAPEUTIC NANOPARTICLES | |
| HUE046596T2 (hu) | Eljárások mitokondriális betegség kezelésére | |
| CO7020919A2 (es) | Derivados de tetrahidro-quinazolinona | |
| EP2919777A4 (en) | TRANSMUCOSAL ADMINISTRATION OF TOCOTRIENOL | |
| PL3090773T3 (pl) | Urządzenia i sposoby przekłuwania kapsułki w celu uwolnienia z niej sproszkowanego leku | |
| LT2914254T (lt) | Kombinacinės terapijos chemoresistencinių vėžių gydymui | |
| IL234606B (en) | Novel methods and composition for treatment of disease | |
| DK2931296T3 (da) | Sygdomsbehandling, der involverer mucin | |
| DK3079655T3 (da) | Inhalerbare lægemidler | |
| HRP20190050T1 (hr) | Farmaceutski pripravci za kombinacijsku terapiju | |
| EP2883547A4 (en) | MEDICINE | |
| HRP20181799T1 (hr) | Optimizirana farmaceutska formula, namijenjena liječenju upalnih promjena jednjaka | |
| EP2789306A4 (en) | TREATMENT SYSTEM | |
| CO7091176A2 (es) | Diagnóstico farmacéutico | |
| HRP20170532T1 (hr) | Derivati kromanila za liječenje mitohondrijske bolesti |